Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...

(Reuters) -Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying ...

The price of crude oil dropped to $62.46 a barrel Monday morning, part of a downward trend that some analysts say could ...

Its amazing results have been hailed by Jeremy Clarkson, Whoopi Goldberg and The Telegraph’s own Allison Pearson, but from next month, the popular weight-loss drug Mounjaro could become inaccessible ...

GLP-1 weight-loss drugs are creating “mortality slippage” in life insurance which is a costly problem that's forcing insurers to rethink how they underwrite.

Novo Nordisk (NYSE:NVO) said Tuesday that Health Canada has expanded the label for its diabetes therapy Ozempic, granting approval for use in patients with chronic kidney disease. The new indication ...

The maker of Ozempic is halving the price of its weight-loss jabs in the US after Donald Trump demanded cheaper drugs for ...

Ozempic price slashed following Donald Trump's demands - will it impact the UK cost? - Novo Nordisk said it has no plans to ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...